HCA HEALTHCARE INC (HCA) Stock Fundamental Analysis
NYSE:HCA • US40412C1018
525.88 USD
-14.69 (-2.72%)
At close: Feb 26, 2026
525.88 USD
0 (0%)
After Hours: 2/26/2026, 8:04:00 PM
HCA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. HCA has an excellent profitability rating, but there are concerns on its financial health. HCA is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year HCA was profitable.
- In the past year HCA had a positive cash flow from operations.
- HCA had positive earnings in each of the past 5 years.
- HCA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- With an excellent Return On Assets value of 11.17%, HCA belongs to the best of the industry, outperforming 96.04% of the companies in the same industry.
- With an excellent Return On Invested Capital value of 21.20%, HCA belongs to the best of the industry, outperforming 95.05% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for HCA is significantly above the industry average of 8.95%.
- The 3 year average ROIC (19.10%) for HCA is below the current ROIC(21.20%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.17% | ||
| ROE | N/A | ||
| ROIC | 21.2% |
ROA(3y)10.06%
ROA(5y)10.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)19.1%
ROIC(5y)18.5%
1.3 Margins
- HCA has a better Profit Margin (8.97%) than 93.07% of its industry peers.
- In the last couple of years the Profit Margin of HCA has grown nicely.
- HCA has a Operating Margin of 15.83%. This is amongst the best in the industry. HCA outperforms 94.06% of its industry peers.
- In the last couple of years the Operating Margin of HCA has grown nicely.
- With an excellent Gross Margin value of 84.96%, HCA belongs to the best of the industry, outperforming 97.03% of the companies in the same industry.
- HCA's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.83% | ||
| PM (TTM) | 8.97% | ||
| GM | 84.96% |
OM growth 3Y1.74%
OM growth 5Y2.35%
PM growth 3Y-1.43%
PM growth 5Y4.26%
GM growth 3Y0.21%
GM growth 5Y0.29%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), HCA is creating value.
- Compared to 1 year ago, HCA has less shares outstanding
- Compared to 5 years ago, HCA has less shares outstanding
- Compared to 1 year ago, HCA has a worse debt to assets ratio.
2.2 Solvency
- HCA has a debt to FCF ratio of 6.04. This is a slightly negative value and a sign of low solvency as HCA would need 6.04 years to pay back of all of its debts.
- The Debt to FCF ratio of HCA (6.04) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 6.04 | ||
| Altman-Z | N/A |
ROIC/WACC2.69
WACC7.89%
2.3 Liquidity
- HCA has a Current Ratio of 0.97. This is a bad value and indicates that HCA is not financially healthy enough and could expect problems in meeting its short term obligations.
- HCA has a Current ratio of 0.97. This is in the lower half of the industry: HCA underperforms 71.29% of its industry peers.
- A Quick Ratio of 0.86 indicates that HCA may have some problems paying its short term obligations.
- With a Quick ratio value of 0.86, HCA is not doing good in the industry: 70.30% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.97 | ||
| Quick Ratio | 0.86 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 28.30% over the past year.
- Measured over the past years, HCA shows a very strong growth in Earnings Per Share. The EPS has been growing by 23.50% on average per year.
- The Revenue has been growing slightly by 7.08% in the past year.
- HCA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.97% yearly.
EPS 1Y (TTM)28.3%
EPS 3Y18.86%
EPS 5Y23.5%
EPS Q2Q%44.58%
Revenue 1Y (TTM)7.08%
Revenue growth 3Y7.87%
Revenue growth 5Y7.97%
Sales Q2Q%6.72%
3.2 Future
- Based on estimates for the next years, HCA will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.36% on average per year.
- The Revenue is expected to grow by 5.48% on average over the next years.
EPS Next Y6.83%
EPS Next 2Y8.55%
EPS Next 3Y10.12%
EPS Next 5Y12.36%
Revenue Next Year3.85%
Revenue Next 2Y4.39%
Revenue Next 3Y4.8%
Revenue Next 5Y5.48%
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 18.53, the valuation of HCA can be described as rather expensive.
- Based on the Price/Earnings ratio, HCA is valued a bit cheaper than the industry average as 73.27% of the companies are valued more expensively.
- HCA is valuated rather cheaply when we compare the Price/Earnings ratio to 27.21, which is the current average of the S&P500 Index.
- With a Price/Forward Earnings ratio of 17.35, HCA is valued on the expensive side.
- Based on the Price/Forward Earnings ratio, HCA is valued a bit cheaper than 70.30% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of HCA to the average of the S&P500 Index (28.13), we can say HCA is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.53 | ||
| Fwd PE | 17.35 |
4.2 Price Multiples
- HCA's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. HCA is cheaper than 71.29% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, HCA is valued a bit cheaper than 75.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.6 | ||
| EV/EBITDA | 10.9 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- HCA has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.71
PEG (5Y)0.79
EPS Next 2Y8.55%
EPS Next 3Y10.12%
5. Dividend
5.1 Amount
- With a yearly dividend of 0.59%, HCA is not a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 0.49, HCA pays a better dividend. On top of this HCA pays more dividend than 82.18% of the companies listed in the same industry.
- With a Dividend Yield of 0.59, HCA pays less dividend than the S&P500 average, which is at 1.80.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.59% |
5.2 History
- The dividend of HCA is nicely growing with an annual growth rate of 44.46%!
- HCA has been paying a dividend for at least 10 years, so it has a reliable track record.
- HCA has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)44.46%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
- HCA pays out 10.01% of its income as dividend. This is a sustainable payout ratio.
- HCA's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP10.01%
EPS Next 2Y8.55%
EPS Next 3Y10.12%
525.88
-14.69 (-2.72%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)01-27 2026-01-27/bmo
Earnings (Next)04-23 2026-04-23/bmo
Inst Owners61.87%
Inst Owner Change-1.86%
Ins Owners0.95%
Ins Owner Change-50.98%
Market Cap120.00B
Revenue(TTM)75.60B
Net Income(TTM)6.78B
Analysts74.84
Price Target537.27 (2.17%)
Short Float %2.64%
Short Ratio3.46
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.59% |
Yearly Dividend2.84
Dividend Growth(5Y)44.46%
DP10.01%
Div Incr Years4
Div Non Decr Years4
Ex-Date03-17 2026-03-17 (0.78)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.3%
Min EPS beat(2)8.05%
Max EPS beat(2)20.55%
EPS beat(4)4
Avg EPS beat(4)11.83%
Min EPS beat(4)8.05%
Max EPS beat(4)20.55%
EPS beat(8)6
Avg EPS beat(8)8.6%
EPS beat(12)9
Avg EPS beat(12)8.06%
EPS beat(16)11
Avg EPS beat(16)6.36%
Revenue beat(2)1
Avg Revenue beat(2)0.18%
Min Revenue beat(2)-1.84%
Max Revenue beat(2)2.2%
Revenue beat(4)1
Avg Revenue beat(4)-0.16%
Min Revenue beat(4)-1.84%
Max Revenue beat(4)2.2%
Revenue beat(8)3
Avg Revenue beat(8)0.16%
Revenue beat(12)7
Avg Revenue beat(12)0.68%
Revenue beat(16)8
Avg Revenue beat(16)0.33%
PT rev (1m)9.19%
PT rev (3m)10.04%
EPS NQ rev (1m)1.11%
EPS NQ rev (3m)0.8%
EPS NY rev (1m)1.48%
EPS NY rev (3m)0.97%
Revenue NQ rev (1m)-0.47%
Revenue NQ rev (3m)-0.53%
Revenue NY rev (1m)-0.52%
Revenue NY rev (3m)-0.7%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.53 | ||
| Fwd PE | 17.35 | ||
| P/S | 1.59 | ||
| P/FCF | 15.6 | ||
| P/OCF | 9.5 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.9 |
EPS(TTM)28.38
EY5.4%
EPS(NY)30.32
Fwd EY5.77%
FCF(TTM)33.71
FCFY6.41%
OCF(TTM)55.37
OCFY10.53%
SpS331.3
BVpS-26.41
TBVpS-71.52
PEG (NY)2.71
PEG (5Y)0.79
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.17% | ||
| ROE | N/A | ||
| ROCE | 26.97% | ||
| ROIC | 21.2% | ||
| ROICexc | 21.71% | ||
| ROICexgc | 28.48% | ||
| OM | 15.83% | ||
| PM (TTM) | 8.97% | ||
| GM | 84.96% | ||
| FCFM | 10.17% |
ROA(3y)10.06%
ROA(5y)10.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)19.1%
ROIC(5y)18.5%
ROICexc(3y)19.68%
ROICexc(5y)19.06%
ROICexgc(3y)25.77%
ROICexgc(5y)29.22%
ROCE(3y)24.29%
ROCE(5y)23.53%
ROICexgc growth 3Y-3.7%
ROICexgc growth 5Y-0.21%
ROICexc growth 3Y8.29%
ROICexc growth 5Y7.06%
OM growth 3Y1.74%
OM growth 5Y2.35%
PM growth 3Y-1.43%
PM growth 5Y4.26%
GM growth 3Y0.21%
GM growth 5Y0.29%
F-Score7
Asset Turnover1.25
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 6.04 | ||
| Debt/EBITDA | 2.69 | ||
| Cap/Depr | 140.34% | ||
| Cap/Sales | 6.54% | ||
| Interest Coverage | 5.42 | ||
| Cash Conversion | 81.59% | ||
| Profit Quality | 113.38% | ||
| Current Ratio | 0.97 | ||
| Quick Ratio | 0.86 | ||
| Altman-Z | N/A |
F-Score7
WACC7.89%
ROIC/WACC2.69
Cap/Depr(3y)147.23%
Cap/Depr(5y)143.02%
Cap/Sales(3y)6.92%
Cap/Sales(5y)6.83%
Profit Quality(3y)100.23%
Profit Quality(5y)90.24%
High Growth Momentum
Growth
EPS 1Y (TTM)28.3%
EPS 3Y18.86%
EPS 5Y23.5%
EPS Q2Q%44.58%
EPS Next Y6.83%
EPS Next 2Y8.55%
EPS Next 3Y10.12%
EPS Next 5Y12.36%
Revenue 1Y (TTM)7.08%
Revenue growth 3Y7.87%
Revenue growth 5Y7.97%
Sales Q2Q%6.72%
Revenue Next Year3.85%
Revenue Next 2Y4.39%
Revenue Next 3Y4.8%
Revenue Next 5Y5.48%
EBIT growth 1Y13.44%
EBIT growth 3Y9.74%
EBIT growth 5Y10.5%
EBIT Next Year32.37%
EBIT Next 3Y13.44%
EBIT Next 5Y10.72%
FCF growth 1Y36.41%
FCF growth 3Y23.07%
FCF growth 5Y3.76%
OCF growth 1Y20.18%
OCF growth 3Y14.03%
OCF growth 5Y6.48%
HCA HEALTHCARE INC / HCA FAQ
What is the fundamental rating for HCA stock?
ChartMill assigns a fundamental rating of 5 / 10 to HCA.
What is the valuation status of HCA HEALTHCARE INC (HCA) stock?
ChartMill assigns a valuation rating of 5 / 10 to HCA HEALTHCARE INC (HCA). This can be considered as Fairly Valued.
What is the profitability of HCA stock?
HCA HEALTHCARE INC (HCA) has a profitability rating of 9 / 10.
What is the financial health of HCA HEALTHCARE INC (HCA) stock?
The financial health rating of HCA HEALTHCARE INC (HCA) is 2 / 10.
Can you provide the expected EPS growth for HCA stock?
The Earnings per Share (EPS) of HCA HEALTHCARE INC (HCA) is expected to grow by 6.83% in the next year.